Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Analyst Ratings
Downgrades
News
Jefferies Downgrades AstraZeneca to Hold
Jefferies analyst Peter Welford downgrades AstraZeneca (NASDAQ:AZN) from Buy to Hold.
by
Benzinga Newsdesk
December 7, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0
Jefferies analyst Peter Welford downgrades AstraZeneca (NASDAQ:
AZN
) from Buy to Hold.
Total
0
Shares
Share
0
Tweet
0
Share
0
Share
0
Share
0
Share
0